| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vanda Pharmaceuticals Inc. (VNDA) has 1 insider with recent SEC Form 4 filings, including 0 buys and 14 sells. VNDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.34M | $14.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 28, 2020 | Dugan Richard W | Director | Sale+OE | 10,129 | $11.04 | $111,805.93 | -20.0% | |
| Mar 3, 2020 | Williams Timothy69 | SVP &General Counsel | Sell | 4,385 | $10.36 | $45,439.57 | -2.6% | |
| Mar 3, 2020 | Polymeropoulos Mihael Hristos77 | President And CEO | Sell | 15,580 | $10.70 | $166,755.68 | -0.6% | |
| Mar 3, 2020 | Kelly James Patrick | EVP &Chief Financial Officer | Sell | 18,857 | $10.36 | $195,446.02 | -4.7% | |
| Mar 3, 2020 | Birznieks Gunther61 | SVP, Business Development | Sell | 17,758 | $10.23 | $181,670.20 | -5.2% | |
| Mar 2, 2020 | Reverberi Gian Piero | SVP &Chief Commercial Officer | Sell | 1,450 | $10.18 | $14,755.20 | -0.9% | |
| Jan 2, 2020 | Reverberi Gian Piero | SVP &Chief Commercial Officer | Sell | 1,155 | $16.06 | $18,550.69 | -0.7% | |
| Jan 2, 2020 | Polymeropoulos Mihael Hristos77 | President And CEO | Sell | 9,467 | $16.00 | $151,492.83 | -0.8% | |
| Jan 2, 2020 | Kelly James Patrick | EVP &Chief Financial Officer | Sell | 4,020 | $15.94 | $64,086.04 | -1.9% | |
| Jan 2, 2020 | Birznieks Gunther61 | SVP, Business Development | Sell | 4,020 | $15.93 | $64,021.31 | -2.7% |